Pliant Therapeutics Announces Appointment of Lily Cheung as

SOUTH SAN FRANCISCO, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused...

Related Keywords

Bernard Coulie ,Lily Cheung ,Christopher Keenan ,Linkedin ,Twitter ,Pliant Therapeutics Inc ,Nasdaq ,Novartis ,Johnson Company ,Human Resources At Rigel Pharmaceuticals ,Facebook ,National Semiconductor ,Covad Communications ,San Francisco State University ,Drug Administration ,United Behavioral Health ,Youtube ,Corporate Communications ,European Medicines Agency ,Janssen Pharmaceuticals ,Actelion Pharmaceuticals Inc ,Chief Human Resources ,Human Resources ,Vice President ,Rigel Pharmaceuticals ,Actelion Pharmaceuticals ,United Behavioral ,San Francisco State ,Chief Executive Officer ,Pliant Therapeutics ,Fast Track Designation ,Orphan Drug Designation ,Private Securities Litigation Reform Act ,Financial Condition ,Annual Report ,Quarterly Report ,Media Contact ,Investor Relations ,Nasdaq Plrx ,Nc ,